Press Releases

Slope announced general availability of its interactive Study Dashboard for Sponsors to address challenges coordinating and overseeing clinical supply chain management for one or more clinical trials across multiple research sites.

Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced hiring two leaders with deep clinical trial expertise: Ben Carmel as Chief Revenue Officer and Matt Smith as Research Site Development Vice President.

Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced that it has been identified as a Sample Vendor in the 2022 Gartner Hype Cycle for Life Science Clinical Development, 2022. Slope was named in the Clinical Trial Resource Management category. Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, and early-phase clinical trials in areas such as oncology, gene therapy, and rare disease.

Slope, provider of the first eClinical Supply Chain Management (eCSCM) platform, announced hiring the clinical research leader, Hope Meely, as Chief Clinical Officer. In her new role, Hope will be instrumental in educating the industry on the new eCSCM software as a service (SaaS) category. Hope will help clinical trial sponsors and research sites understand how replacing existing manual and paper-driven clinical supply chain processes with the Slope eCSCM platform will reduce clinical trial risk and costs, improve the productivity of clinical trial collaborators, and increase subject retention.

Slope today announced the closing of a $20 million Series A financing, led by global venture capital firm New Enterprise Associates, Inc. (NEA), to accelerate go-to-market efforts and further expand into decentralized and direct-to-patient clinical trials.